‘Worrisome Deficiencies’ Noted in Warning to Polish Drugmaker

The FDA has warned Polish pharmaceutical manufacturer Jelfa SA, citing “worrisome” cGMP deficiencies, including a number of repeat violations.
Drug GMP Report